NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 61
Auteur Titel [ Jaar(Asc)]
Filters: Trefwoord is Humans  [Alle filters opschonen]
2019
Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, A von Borries KL, Schene AH, Van der Ven AJAM, Schellekens AFA.  2019.  Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS One. 14(2):e0207970.
Nass GCM, van Rens LW, Dijkstra BAG.  2019.  Clinicians' perceptions for indicating and contra-indicating integrated treatment for SUD and comorbid PTSD, a vignette study. Subst Abuse Treat Prev Policy. 14(1):7.
van den Brink WGMoerman-, van Aken L, Verschuur EML, Walvoort SJW, Egger JIM, Kessels RPC.  2019.  Executive Dysfunction in Patients With Korsakoff's Syndrome: A Theory-Driven Approach. Alcohol Alcohol. 54(1):23-29.
2018
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.. Psychiatry Res. 259:412-421.
Knuijver T, Belgers M, Markus W, Verkes R-J, van Oosteren T, Schellekens AFA.  2018.  Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. J Clin Psychopharmacol. 38(6):646-648.
Kraan AEM, Dijkstra BAG, Markus W.  2018.  Treatment delivery of the community reinforcement approach in outpatient addiction treatment.. Eval Program Plann. 70:61-66.
2017
van Noorden MS, Kamal R, Beurmanjer H, Dijkstra BAG, Schellekens AFA.  2017.  [Reaction on 'Hypernatremia caused by treatment with GHB obtained via a doctor's prescription'].. Tijdschr Psychiatr. 59(3):195-196.
2016
Kiewik M, VanDerNagel JEl, Kemna LEM, Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial.. J Intellect Disabil Res. 60(3):191-200.
2015
Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  Effectiveness and Organization of Addiction Medicine Training Across the Globe.. Eur Addict Res. 21(5):223-39.
2014
Pujol J, Blanco-Hinojo L, Batalla A, López-Sola C, Harrison BJ, Soriano-Mas C, Crippa JA, Fagundo AB, Deus J, de la Torre R et al..  2014.  Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users.. J Psychiatr Res. 51:68-78.
Batalla A, Soriano-Mas C, López-Sola C, Torrens M, Crippa JA, Bhattacharyya S, Blanco-Hinojo L, Fagundo AB, Harrison BJ, Nogué S et al..  2014.  Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.. Addict Biol. 19(4):722-32.
Batalla A, Crippa JA, Busatto GF, Guimaraes FS, Zuardi AW, Valverde O, Atakan Z, McGuire PK, Bhattacharyya S, Martin-Santos R.  2014.  Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.. Curr Pharm Des. 20(13):2168-85.
2013
Barrio P, Batalla A, Castellví P, Hidalgo D, García M, Ortiz A, Grande I, Pons A, Parellada E.  2013.  Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.. Int Clin Psychopharmacol. 28(4):164-70.
Qurishi R, Sonneborn C, de Jong-Arts M, DeJong CA.  2013.  Premenstrual syndrome and self-medication with opioids.. J Addict Med. 7(1):79-82.
Batalla A, Garcia-Rizo C, Castellví P, Fernandez-Egea E, Yücel M, Parellada E, Kirkpatrick B, Martin-Santos R, Bernardo M.  2013.  Screening for substance use disorders in first-episode psychosis: implications for readmission.. Schizophr Res. 146(1-3):125-31.
Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué S, Torrens M, Pujol J, Farré M, Martin-Santos R.  2013.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.. PLoS One. 8(2):e55821.
Kok T, de Haan HA, van der Velden HJW, van der Meer M, Najavits LM, DeJong CA.  2013.  Validation of two screening instruments for PTSD in Dutch substance use disorder inpatients.. Addict Behav. 38(3):1726-31.
2012
Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Farré M et al..  2012.  Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.. Curr Pharm Des. 18(32):4966-79.
Carpentier PJ, Knapen LJM, Van Gogh MT, Buitelaar JK, DeJong CA.  2012.  Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence.. J Addict Dis. 31(1):45-59.
Vruwink FJ, Noorthoorn EO, Nijman HLI, VanDerNagel JEl, Hox JJ, Mulder CL.  2012.  Determinants of seclusion after aggression in psychiatric inpatients.. Arch Psychiatr Nurs. 26(4):307-15.
Schellekens A, Mulders PCR, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2012.  Early-onset alcohol dependence increases the acoustic startle reflex.. Alcohol Clin Exp Res. 36(6):1075-83.
DeJong CA, Kamal RM, Dijkstra BAG, de Haan HA.  2012.  Gamma-hydroxybutyrate detoxification by titration and tapering.. Eur Addict Res. 18(1):40-5.
de Haan HA, Schellekens A, van der Palen J, Verkes RJ, Buitelaar JK, DeJong CA.  2012.  The level of alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment.. Am J Drug Alcohol Abuse. 38(4):299-304.
Iskandar S, Kamal RM, DeJong CA.  2012.  Psychiatric comorbidity in injecting drug users in Asia and Africa.. Curr Opin Psychiatry. 25(3):213-8.
Schellekens A, Franke B, Ellenbroek B, Cools AR, DeJong CA, Buitelaar JK, Verkes RJ.  2012.  Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.. Arch Gen Psychiatry. 69(4):339-48.

Pagina's